QSA's Week in BioPharma (#2, 2024)

New Pharmacare Act receives Royal Assent; PMPRB gains new appointee; Research support system engagement report released; EVAH Corp receives substantial CED funding.

QSA's Week in BioPharma (#2, 2024)

Start Date: 2024-10-12
End Date: 2024-10-18

Top Headlines

Main Stories

Pharmacare Act Receives Royal Assent

The first phase of Canada's national Pharmacare plan has officially become law following the Royal Assent of the Pharmacare Act. This initial phase will provide free access to contraceptive prescriptions and diabetes medications, including insulin, to Canadians. This legislative milestone marks a significant shift in national healthcare, aiming to alleviate the financial burden of essential medications for millions of Canadians. The Act's implementation focuses on ensuring equitable access to necessary health services, aligning with broader goals of improving public health outcomes.

Sources: ['Social Media: x.com', 'Social Media: x.com', 'Social Media: x.com']